Also categorized in News:
Newcastle University Centre for Childhood Cancer clinical trials will push boundaries - The Journal
x hide permanently

T-VEC becomes first viral immunotherapy approved in Europe

The Institute of Cancer Research, London

A viral immunotherapy for cancer has become the first of its kind to be approved by the European Medicines Agency for use in adults with advanced melanoma.

Mentions: Immunotherapy Oncolytic Viruses